Next Article in Journal / Special Issue
SARS-CoV-2, Influenza and Other Respiratory Viruses: Epidemiology, Burden of Disease, and Preventive Measures
Previous Article in Journal
Evaluation of Polymyxin B as a Novel Vaccine Adjuvant and Its Immunological Comparison with FDA-Approved Adjuvants
Previous Article in Special Issue
Factors Associated with Influenza Vaccination Among Urban Community-Dwelling Chinese Elderly: Results from a Multicity Cross-Sectional Study
 
 
Article

Article Versions Notes

Vaccines 2025, 13(12), 1233; https://doi.org/10.3390/vaccines13121233
Action Date Notes Link
article html file updated 10 December 2025 03:24 CET Update https://www.mdpi.com/2076-393X/13/12/1233/html
article pdf uploaded. 10 December 2025 03:23 CET Updated version of record https://www.mdpi.com/2076-393X/13/12/1233/pdf
article xml uploaded. 10 December 2025 03:23 CET Update https://www.mdpi.com/2076-393X/13/12/1233/xml
article xml file uploaded 10 December 2025 03:23 CET Update -
article html file updated 9 December 2025 12:18 CET Original file -
article pdf uploaded. 9 December 2025 12:14 CET Version of Record https://www.mdpi.com/2076-393X/13/12/1233/pdf-vor
article xml uploaded. 9 December 2025 12:14 CET Update -
article xml file uploaded 9 December 2025 12:14 CET Original file -
Back to TopTop